Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 226 AL 240

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease

Li Y, Lin S, Gu Z, Chen L, He B.

Bioorg Med Chem Lett. 2022 Nov 15;76:129015. doi: 10.1016/j.bmcl.2022.129015. Epub 2022 Oct 5.

Evaluating Cannabis sativa L.'s neuroprotection potential: From bench to bedside

Laws JS 3rd, Smid SD.

Phytomedicine. 2022 Dec;107:154485. doi: 10.1016/j.phymed.2022.154485. Epub 2022 Sep 29.

Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment

Hill MA, Gammie SC.

Sci Rep. 2022 Oct 13;12(1):17189. doi: 10.1038/s41598-022-22179-z.

Vascular Considerations for Amyloid Immunotherapy

Foley KE, Wilcock DM.

Curr Neurol Neurosci Rep. 2022 Nov;22(11):709-719. doi: 10.1007/s11910-022-01235-1. Epub 2022 Oct 21.

Meta analysis of aerobic exercise improving intelligence and cognitive function in patients with Alzheimer's disease

Zhou XP, Zhang LM, Chen GQ, Wang SW, He JF, Li Z, Zhang BS.

Medicine (Baltimore). 2022 Oct 21;101(42):e31177. doi: 10.1097/MD.0000000000031177.

Effectiveness of Physical Exercise on Alzheimer's disease. A Systematic Review

Cámara-Calmaestra R, Martínez-Amat A, Aibar-Almazán A, Hita-Contreras F, de Miguel Hernando N, Achalandabaso-Ochoa A.

J Prev Alzheimers Dis. 2022;9(4):601-616. doi: 10.14283/jpad.2022.57.

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults

Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.

J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.

Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate

Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO.

J Prev Alzheimers Dis. 2022;9(4):780-790. doi: 10.14283/jpad.2022.63.

Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics

Hirschfeld LR, Risacher SL, Nho K, Saykin AJ.

Transl Neurodegener. 2022 Oct 26;11(1):47. doi: 10.1186/s40035-022-00321-1.

Polypharmacy in Older Adults with Alzheimer's Disease

Esumi S, Ushio S, Zamami Y.

Medicina (Kaunas). 2022 Oct 13;58(10):1445. doi: 10.3390/medicina58101445.

Targeting Alzheimer's Disease: The Critical Crosstalk between the Liver and Brain

Huang Z, Lin HWK, Zhang Q, Zong X.

Nutrients. 2022 Oct 14;14(20):4298. doi: 10.3390/nu14204298.

Aducanumab for the treatment of Alzheimer's disease

Tagliapietra M.

Drugs Today (Barc). 2022 Oct;58(10):465-477. doi: 10.1358/dot.2022.58.10.3422314.

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias